“We need international collaboration to save the world. And I hope that nobody will forget it,” she stressed.
China shared the initial information about the virus DNA with all other countries so that every one of them could work on vaccines and treatments. This kind of collaboration should continue for the benefit of all humankind, according to the professor.
There are approximately eight main directions taken to work out a vaccine for COVID-19. Such a variety of possibilities increased the odds of finding the right way to the desired result, according to Zimhony.
“The major game-changer to overcome this pandemic is vaccine development,” Zimhony said, who believes that the first clinical implications of the intense vaccine research will be available in six months.
“It seems there is no proper treatment for COVID-19 disease patients, and the only effective global cure would be a vaccine,” she noted.
The biggest challenge in the work, according to Regev-Yochay, is to find a completely safe vaccine for everybody and a reliable way to deliver it to all kinds of people with different health situations.
“We need to be very cautious with vaccines. It’s much more complicated than clinical trials with the drugs,” stressed Regev-Yochay.
Many COVID-19 patients don’t have symptoms or have mild ones, “so we need to make sure we don’t inject them with vaccines, drugs, or chemicals that could do more harm than good,” she said.
International sharing of information could help researchers compare the effectiveness of different vaccines and speed up the progress of the development.
According to the statistics of the World Health Organization, currently more than 130 COVID-19 candidate vaccines are being developed worldwide, with about 10 of them being already in clinical evaluation.
Among the vaccine challenges is also its mass production for the use of all of humanity, which calls for global cooperation.
Ben-Yehuda said she believes new technologies of computational medicine and international sharing of big data could help create personalized medicine for COVID-19 infection, as the virus affects people differently.